Screener
Bruker BRKR Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 46.4%-1.8pp | 45.3%-3.7pp | 45.9%-3.1pp | 47.2%-1.8pp | 48.3%-1.4pp | |
| Operating margin | -0.9%-6.2pp | 1.3%-5.0pp | 2%-5.5pp | 1.9%-6.9pp | 5.3%-5.6pp | |
| Returns | ||||||
| Return on invested capital | -0.7%-3.3pp | 0.6%-2.9pp | 0.8%-3.8pp | 0.8%-6.4pp | 2.5%-6.6pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×0.0× | 0.6×-0.1× | 0.6×-0.1× | 0.5×-0.1× | 0.6×-0.1× | |
| Liquidity | ||||||
| Current ratio | 1.8×+0.2× | 1.6×0.0× | 1.7×+0.1× | 1.9×+0.2× | 1.6×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×-0.6× | 0.7×-0.5× | 0.8×-0.4× | 0.8×-0.5× | 1.3×+0.1× | |
| Net debt / EBITDA | 8.2×+2.3× | 5.6×+1.0× | 6.1×+1.3× | 6.1×+1.1× | 5.9×+1.6× | |
| Per Share | ||||||
| Book value per share | $15.76+31.4% | $16.16+33.9% | $16.18+35.8% | $16.02+34.8% | $11.99-0.8% | |
| Valuation | ||||||
| Market capitalization | $7.99B+71.7% | $5.5B-13.2% | $7.16B-19.5% | $4.93B-52.9% | $6.01B-37.8% | |
| Price / sales | 2.3×+0.9× | 1.6×-0.2× | 2.1×-0.6× | 1.4×-1.8× | 1.7×-1.3× | |
| Price / book | 3.3×+0.8× | 2.2×-1.2× | 2.9×-2.1× | 2×-3.8× | 3.3×-2.1× | |
| EV / EBITDA | 48.2×+30.5× | 25.6×+5.9× | 30.9×+5.8× | 23.8×-4.3× | 21.2×-3.1× | |
| Dividend yield | 0.3%-0.4pp | 0.4%-0.1pp | 0.3%0.0pp | 0.5%+0.2pp | 0.5%+0.2pp |
FAQ
- What are Bruker's profit margins?
- Bruker (BRKR) runs a 46.4% gross margin and a -0.9% operating margin, with a -0.6% net margin.
- Where do Bruker's ratios come from?
- Every ratio is computed from Bruker's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
